Baker Bros. Advisors LP Tricida, Inc. Transaction History

Baker Bros. Advisors LP

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$8.51 - $13.6 $1.56 Million - $2.49 Million	-182,800 Reduced 12.16%	1,320,290 $13.8 Million
Q2 2022 Aug 15, 2022	SELL	$7.31 - $11.85 $1.67 Million - $2.71 Million	-228,624 Reduced 13.2%	1,503,090 $14.6 Million
Q1 2022 May 16, 2022	BUY	$7.35 - $10.63 $3.28 Million - $4.75 Million	446,700 Added 34.76%	1,731,714 $14.2 Million
Q4 2021 Feb 14, 2022	BUY	$4.19 - $9.56 $1.04 Million - $2.37 Million	247,582 Added 23.86%	1,285,014 $12.3 Million
Q3 2021 Nov 15, 2021	BUY	$3.56 - $4.64 $1.1 Million - $1.43 Million	308,132 Added 42.25%	1,037,432 $4.81 Million
Q1 2021 May 17, 2021	BUY	$4.52 - $7.8 $451,999 - $780,000	100,000 Added 15.89%	729,300 $3.86 Million
Q4 2020 Feb 16, 2021	BUY	$4.37 - $9.46 $2.75 Million - $5.95 Million	629,300 New	629,300 $4.44 Million
Q3 2020 Nov 16, 2020	SELL	$8.56 - $26.93 $6.74 Million - $21.2 Million	-787,582 Closed	0 $0
Q2 2020 Aug 14, 2020	SELL	$21.21 - $31.55 $39.8 Million - $59.3 Million	-1,878,433 Reduced 70.46%	787,582 $21.6 Million
Q1 2020 May 15, 2020	BUY	$18.43 - $38.04 $12.8 Million - $26.5 Million	696,110 Added 35.34%	2,666,015 $58.7 Million
Q2 2019 Aug 14, 2019	BUY	$31.16 - $39.46 $5.19 Million - $6.58 Million	166,667 Added 9.24%	1,969,905 $77.7 Million
Q1 2019 May 15, 2019	BUY	$19.96 - $38.62 $4.06 Million - $7.85 Million	203,238 Added 12.7%	1,803,238 $69.6 Million
Q2 2018 Aug 14, 2018	BUY	$26.0 - $29.9 $41.6 Million - $47.8 Million	1,600,000 New	1,600,000 $47.8 Million

30K

124K

46.5K

Ticker TCDA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,668,900
Market Cap $557K
Description
Tricida, Inc. operates as a pharmaceutical company. It focuses on the development and commercialization of veverimer (TRC101), a non-absorbed orally-administered polymer that has completed Phase III trial to treat metabolic acidosis in patients with chronic kidney disease by binding and removing acid from the gastrointestinal track. The company ...

Get notified when there are updates to the investment portfolio of Baker Bros. Advisors LP, based on Form 13F filings with the SEC.

Stay updated on Baker Bros. Advisors LP with notifications on news.